At the same time, by IHC assay, we observed the elevated expression of MET in tissues from NEPC patients compared to that from either CRPC or primary PCa patients, which exhibited a similar profiling to that of PAX6 (Fig. 7c). The gene discussed is PAX6; the disease is posterior cortical atrophy.